Image pharmaphorum Editor Market Access Around the world in pharma events Stay up to date with key industry meetings and conferences in 2023 Market Access How to solve a problem like DTx in Europe? The promise of digital therapeutics (DTx) has been widely discussed and debated since the term first began to emerge back in the early 2010s. Market Access CSL opens a new R&D facility in Waltham, Massachusetts On March 27th, global biopharma company CSL opened a new R&D facility in Waltham, Massachusetts. Market Access What the HRT is happening with menopause care in the UK? Menopause is a natural process that occurs as women age and marks the end of their reproductive years. Load more results
Market Access Around the world in pharma events Stay up to date with key industry meetings and conferences in 2023
Market Access How to solve a problem like DTx in Europe? The promise of digital therapeutics (DTx) has been widely discussed and debated since the term first began to emerge back in the early 2010s.
Market Access CSL opens a new R&D facility in Waltham, Massachusetts On March 27th, global biopharma company CSL opened a new R&D facility in Waltham, Massachusetts.
Market Access What the HRT is happening with menopause care in the UK? Menopause is a natural process that occurs as women age and marks the end of their reproductive years.
R&D Allogeneic cell therapy isn’t dead, with Brian Culley Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
